Company Overview of Trellis Bioscience, Inc.
Trellis Bioscience, Inc. discovers and develops human antibody therapeutics for infectious disease and oncology indications. The company provides CellSpot, a technology to find rare antibodies that are identified and recovered from human blood cells; and identify anti-drug antibodies for pharmaceutical partners. Its pipeline includes discovering monoclonal antibodies that focuses on eliminating infectious diseases; and multiple native human antibodies from healthy blood donors against various cancer immune checkpoint targets, including recalcitrant cancers. The company was founded in 1998 and is based in Menlo Park, California.
1505-B O'Brien Drive
Menlo Park, CA 94025
Founded in 1998
Key Executives for Trellis Bioscience, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Trellis Bioscience, Inc., please visit www.trellisbio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.